Figure 1From: Virological and immunological response to three boosted protease inhibitor regimensProportion of patients below the detection limit (<50 copies/mL) and CD4 cell count-development during 48 weeks on three different boosted double protease inhibitor regimens – without further additional antiretrovirals.Back to article page